EP4102997A1 - Improved yeasts for brewing - Google Patents
Improved yeasts for brewingInfo
- Publication number
- EP4102997A1 EP4102997A1 EP21710731.7A EP21710731A EP4102997A1 EP 4102997 A1 EP4102997 A1 EP 4102997A1 EP 21710731 A EP21710731 A EP 21710731A EP 4102997 A1 EP4102997 A1 EP 4102997A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- riboflavin
- beer
- less
- seq
- yeast cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 46
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 411
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 219
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 219
- 239000002151 riboflavin Substances 0.000 claims abstract description 219
- 229960002477 riboflavin Drugs 0.000 claims abstract description 219
- 235000013405 beer Nutrition 0.000 claims abstract description 168
- 238000000034 method Methods 0.000 claims abstract description 76
- 239000000796 flavoring agent Substances 0.000 claims abstract description 45
- 235000019634 flavors Nutrition 0.000 claims abstract description 42
- 108090000623 proteins and genes Proteins 0.000 claims description 90
- 210000005253 yeast cell Anatomy 0.000 claims description 61
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 57
- 229920001184 polypeptide Polymers 0.000 claims description 54
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 54
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 45
- 239000012634 fragment Substances 0.000 claims description 39
- 108090000604 Hydrolases Proteins 0.000 claims description 30
- 230000015572 biosynthetic process Effects 0.000 claims description 24
- 108030000116 Riboflavinases Proteins 0.000 claims description 23
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 22
- 150000007523 nucleic acids Chemical class 0.000 claims description 22
- 108091026890 Coding region Proteins 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 15
- 108020004707 nucleic acids Proteins 0.000 claims description 15
- 101100434663 Bacillus subtilis (strain 168) fbaA gene Proteins 0.000 claims description 9
- 101150095274 FBA1 gene Proteins 0.000 claims description 9
- 238000003860 storage Methods 0.000 claims description 9
- 241001123227 Saccharomyces pastorianus Species 0.000 claims description 8
- 230000002068 genetic effect Effects 0.000 claims description 8
- 241000235070 Saccharomyces Species 0.000 claims description 7
- 241000235648 Pichia Species 0.000 claims description 6
- SGSVWAYHEWEQET-SCRDCRAPSA-N 1,5-dihydroriboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O SGSVWAYHEWEQET-SCRDCRAPSA-N 0.000 claims description 3
- 241000722885 Brettanomyces Species 0.000 claims description 3
- 101100334009 Caenorhabditis elegans rib-2 gene Proteins 0.000 claims description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 3
- 241000235644 Issatchenkia Species 0.000 claims description 3
- 241000235649 Kluyveromyces Species 0.000 claims description 3
- 241000235346 Schizosaccharomyces Species 0.000 claims description 3
- 241000235013 Yarrowia Species 0.000 claims description 3
- 239000000203 mixture Substances 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 78
- 210000004027 cell Anatomy 0.000 description 47
- 102000004169 proteins and genes Human genes 0.000 description 38
- 230000014509 gene expression Effects 0.000 description 37
- 238000012217 deletion Methods 0.000 description 32
- 230000037430 deletion Effects 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 26
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 26
- 108091033409 CRISPR Proteins 0.000 description 24
- 230000010354 integration Effects 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 21
- 102000004157 Hydrolases Human genes 0.000 description 21
- 108091033319 polynucleotide Proteins 0.000 description 20
- 102000040430 polynucleotide Human genes 0.000 description 20
- 239000002157 polynucleotide Substances 0.000 description 20
- 108090000854 Oxidoreductases Proteins 0.000 description 19
- 102000004316 Oxidoreductases Human genes 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 19
- 230000002441 reversible effect Effects 0.000 description 17
- 238000000855 fermentation Methods 0.000 description 15
- 230000004151 fermentation Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 108091027544 Subgenomic mRNA Proteins 0.000 description 14
- 230000004186 co-expression Effects 0.000 description 13
- 101150087675 RIB5 gene Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 235000021577 malt beverage Nutrition 0.000 description 11
- 101150009006 HIS3 gene Proteins 0.000 description 10
- 240000005979 Hordeum vulgare Species 0.000 description 10
- 235000007340 Hordeum vulgare Nutrition 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 102100026548 Caspase-8 Human genes 0.000 description 9
- 101000983528 Homo sapiens Caspase-8 Proteins 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 108010076504 Protein Sorting Signals Proteins 0.000 description 8
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108091029795 Intergenic region Proteins 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000013613 expression plasmid Substances 0.000 description 7
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 7
- 239000011768 flavin mononucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 229940013640 flavin mononucleotide Drugs 0.000 description 6
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000002018 overexpression Effects 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 239000006152 selective media Substances 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- LJUQGASMPRMWIW-UHFFFAOYSA-N 5,6-dimethylbenzimidazole Chemical compound C1=C(C)C(C)=CC2=C1NC=N2 LJUQGASMPRMWIW-UHFFFAOYSA-N 0.000 description 5
- 241000266847 Mephitidae Species 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 4
- 101000727821 Homo sapiens RING1 and YY1-binding protein Proteins 0.000 description 4
- 102100029760 RING1 and YY1-binding protein Human genes 0.000 description 4
- 101100213465 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YHK8 gene Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000005360 mashing Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000004458 spent grain Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- GYDPOKGOQFTYGW-UHFFFAOYSA-N 3-Methyl-2-butene-1-thiol Chemical compound CC(C)=CCS GYDPOKGOQFTYGW-UHFFFAOYSA-N 0.000 description 3
- 101100545230 Arabidopsis thaliana ZDS1 gene Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 102100027944 Flavin reductase (NADPH) Human genes 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 108020005004 Guide RNA Proteins 0.000 description 3
- 235000008694 Humulus lupulus Nutrition 0.000 description 3
- 101150010617 MCH5 gene Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000856658 Microbacterium maritypicum Species 0.000 description 3
- 239000012901 Milli-Q water Substances 0.000 description 3
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 3
- 101100439293 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CLB5 gene Proteins 0.000 description 3
- 101100152885 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) THI22 gene Proteins 0.000 description 3
- 241001063879 Saccharomyces eubayanus Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000004464 cereal grain Substances 0.000 description 3
- 150000002211 flavins Chemical class 0.000 description 3
- 108091008053 gene clusters Proteins 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 235000021440 light beer Nutrition 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 2
- 101100302211 Arabidopsis thaliana RNR2A gene Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101710157404 Flavin reductase Proteins 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001633954 Microbacterium oxydans Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 101150002896 RNR2 gene Proteins 0.000 description 2
- 102000004431 Riboflavin transporter Human genes 0.000 description 2
- 101710180428 Riboflavin transporter MCH5 Proteins 0.000 description 2
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 2
- 241001023102 Saccharomyces pastorianus Weihenstephan 34/70 Species 0.000 description 2
- 241000235343 Saccharomycetales Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101150001810 TEAD1 gene Proteins 0.000 description 2
- 101150074253 TEF1 gene Proteins 0.000 description 2
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 2
- 235000015107 ale Nutrition 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 235000020008 bock Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 150000002085 enols Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 235000020007 pale lager Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000020004 porter Nutrition 0.000 description 2
- 230000001323 posttranslational effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108020001053 riboflavin transporter Proteins 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UDCFOIBBBVRFEE-UHFFFAOYSA-N 3-methylbut-1-ene-1-thiol Chemical compound CC(C)C=CS UDCFOIBBBVRFEE-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 241000257161 Calliphoridae Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 1
- 229930193815 Isohumulone Natural products 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 102000010722 N-Glycosyl Hydrolases Human genes 0.000 description 1
- 108010063372 N-Glycosyl Hydrolases Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000592795 Paenibacillus sp. Species 0.000 description 1
- 241001326562 Pezizomycotina Species 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108010086211 Riboflavin synthase Proteins 0.000 description 1
- 239000004228 Riboflavin-5'-Phosphate Substances 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000105479 Sinorhizobium meliloti 1021 Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- -1 cell Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000015095 lager Nutrition 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C11/00—Fermentation processes for beer
- C12C11/003—Fermentation of beerwort
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/002—Processes specially adapted for making special kinds of beer using special microorganisms
- C12C12/004—Genetically modified microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12H—PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
- C12H1/00—Pasteurisation, sterilisation, preservation, purification, clarification, or ageing of alcoholic beverages
- C12H1/003—Pasteurisation, sterilisation, preservation, purification, clarification, or ageing of alcoholic beverages by a biochemical process
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01041—Riboflavin reductase (NAD(P)H)(1.5.1.41)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01009—Riboflavin synthase (2.5.1.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/99—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in other compounds (3.5.99)
- C12Y305/99001—Riboflavinase (3.5.99.1)
Definitions
- the present invention relates to improvements in brewers yeast to prevent or inhibit the occurrence of skunk beer
- skunked beer Exposure of beer to sun light can result in the formation of an off-flavor called skunked beer. Brewers refer to this phenomenon as light stmck or sun struck. Formation of skunked flavor in beer is obviously highly undesirable. To prevent the negative interaction between sun light and beer, brewers use glass, dark brown bottles for beer storage. Dark brown bottles partly limit transmission of the visible and UV region of the spectrum. While brown bottles can be used to inhibit development of skunk flavor, brewers frequently use clear or light green bottles for beer storage for reasons related to marketing and product differentiation. Light struck remains a major challenge for beer stored in green or clear bottles.
- 3MBT 3-methylbut-ene- thiol
- Skunky thiol Mechanism for Formation of the Lightstruck Flavor in Beer Revealed by Time-Resolved Electron Paramagnetic Resonance, Bums et al. 2001. Chem. Eur. J. 7 (21): 4553-4561. Skunk)' thiol is formed by the ultraviolet light induced reaction of sulfur containing amino acids with iso-humulones. Formation of 3MBT requires the presence of a photosensitizer which produces free radicals.
- a flavor stabilized beer having low riboflavin wherein the beer has less than 200 ⁇ g/L of riboflavin.
- 3-methyl-but-2-ene-l-thiol 3-methyl-but-2-ene-l-thiol
- the inventors have discovered the by lowering the amount of riboflavin in beer, formation of 3-MBT is inhibited even though beer is exposed to sunlight.
- beer typically has at least 300 ⁇ g/L of riboflavin.
- the beer has less than 100 ⁇ g/L of riboflavin.
- the beer has less than 50 ⁇ g/L of riboflavin.
- the beer has less than 10 ⁇ g/L of riboflavin.
- the beer has less than 5 ⁇ g/L of riboflavin.
- the beer has less than 1 ⁇ g/L of riboflavin.
- the beer has less than 0.5 ⁇ g/L of riboflavin.
- the beer has less than 0.1 ⁇ g/L of riboflavin.
- the flavor stabilized beer has less than 50 ppt (parts per trillion) 3MBT.
- less 40 ppt 3MBT is less than 40 ppt 3MBT.
- less than 30 ppt 3MBT is less than 20 ppt 3MBT.
- less than 10 ppt 3MBT is less than 50 ppt (parts per trillion) 3MBT.
- the amount of 3MBT in the flavor stabilized beer does not increase more than 20% over 3 months, 6 months or 9 months of storage.
- the amount of 3MBT in the flavor stabilized beer does not increase more than 20% over 3 months, 6 months or 9 months of storage.
- not more than 10% over 3 months, 6 months or 9 months of storage does not increase more than 5% over 3 months, 6 months or 9 months.
- the flavor stabilized beer is a 100% malt- based beer.
- a method for preparing a flavor stabilized beer having low riboflavin comprising fermenting a wort having riboflavin with modified yeast cells, derived from parental yeast cells, the modified yeast cells having disrupted riboflavin biosynthesis, whereby the modified yeast cells deplete the riboflavin in the wort to produce the beer having less than 200 ⁇ g/L of riboflavin.
- the beer has less than 100 ⁇ g/L of riboflavin.
- the beer has less than 50 ⁇ g/L of riboflavin.
- the beer has less than 10 ⁇ g/L of riboflavin.
- the beer has less than 5 ⁇ g/L of riboflavin.
- the beer has less than 1 ⁇ g/L of riboflavin.
- the beer has less than 0.5 ⁇ g/L of riboflavin.
- the beer has less than 0.1 ⁇ g/L of riboflavin.
- the modified yeast cells have a genetic disruption of a gene involved in riboflavin biosynthesis.
- the gene is selected from the group consisting of ribl , rib2, rib3, rib4, rib5 or rib7.
- the gene is rib5.
- the modified yeast cells comprise a heterologous nucleic acid encoding Mch5p, providing for enhanced riboflavin uptake by the yeast cell.
- the nucleic acid coding sequence of Mch5p corresponds to SEQ ID NO: 56.
- the Mch5p coding sequence is under the control of a yeast constitutive promoter.
- the promoter is FBA1
- the parental yeast cells are selected from the group consisting of Schizosaccharomyces, Brettanomyces, Kluyveromyces, Yarrowia, Pichia, Candida, Hansenula, Issatchenkia, and Saccharomyces.
- the parental yeast cells are Saccharomyces.
- the parental yeast cells are Saccharomyces cerevisiae and Saccharomyces pastorianus.
- the modified yeast cells have a functionally expressed heterologous riboflavinase.
- the riboflavinase is a riboflavin hydrolase.
- the riboflavin hydrolase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaEl (SEQ ID NO:79) or a riboflavin hydrolase active fragment thereof or MOXRcaE2 (SEQ ID NO: 80) or a riboflavin hydrolase active fragment thereof.
- the riboflavinase is a riboflavin reductase.
- the riboflavin reductase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaBl (SEQ ID NO:81) or a riboflavin reductase active fragment thereof or MOXRcaB2 (SEQ ID NO: 82) or a riboflavin reductase active fragment thereof.
- the modified yeast cells have a riboflavin reductase and a riboflavin hydrolase.
- the riboflavin reductase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaBl (SEQ ID NO:81) or a riboflavin reductase active fragment thereof or MOXRcaB2 (SEQ ID NO: 82) or a riboflavin reductase active fragment thereof and the riboflavin hydrolase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaEl (SEQ ID NO:79) or a riboflavin hydrolase active fragment thereof or MOXRcaE2 (SEQ ID NO: 80) or a riboflavin hydrolase active fragment thereof.
- the riboflavinase is a riboflavin destructase.
- the riboflavin destructase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to SmeBluBl (SEQ ID NO: 83) or a riboflavin destructase active fragment thereof or PspBluBl (SEQ ID NO:84) or a riboflavin destructase active fragment thereof.
- a beer is presented made according to any of the methods discussed above.
- a method for preparing a flavor stabilized beer having reduced riboflavin comprising fermenting a wort having riboflavin with modified yeast cells, derived from parental yeast cells, said modified yeast cells having disrupted riboflavin biosynthesis, whereby the modified yeast cells deplete the riboflavin in the wort to produce beer having at least 10% less riboflavin produced than a beer fermented with the parental yeast cells.
- the beer has at least 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 99% less riboflavin than a beer fermented with the parental yeast cells.
- the parental yeast is Saccharomyces pastorianus.
- the strain is W34/70.
- FIG. 1 depicts targeted genome integration of a cassette.
- FIG. 2 depicts the strain lineage of the RcaBl, RcaEl and BluB expressing W34/70 transformants.
- FIG. 3 depicts the riboflavin concentrations in wort after brewing with modified yeast strains.
- FIG. 4 depicts the Fermax Gold strain lineage with rib5 deletion and Mch5 overexpression.
- FIG. 5 depicts riboflavin concentration in media after growing with modified yeast strains.
- SEQ ID NO: 1 is the ENOl promoter DNA sequence.
- SEQ ID NO:2 is the DNA coding sequence for MoxRcaBl riboflavin reductase.
- SEQ ID NO:3 is the FBA1L2 promoter DNA sequence.
- SEQ ID NO:4 is the DNA sequence for MoxRcaEl riboflavin hydrolase.
- SEQ ID NO:5 is the ADH1 terminator DNA sequence.
- SEQ ID NO: 6 is the DNA coding sequence for SmeBluBl riboflavin destructase.
- SEQ ID NO:7 is the DNA coding sequence for PspBluBl riboflavin destructase.
- SEQ ID NO: 8 is the FBA1 terminator DNA sequence.
- SEQ ID NO: 9 is the TEF1 promoter DNA sequence.
- SEQ ID NO: 10 is the KanMX marker DNA sequence.
- SEQ ID NO: 11 is the TEF1 terminator DNA sequence.
- SEQ ID NO: 12 is the 2-micron DNA sequence.
- SEQ ID NO: 13 is the RNR2 promoter DNA sequence.
- SEQ ID NO: 14 is the Cas9 DNA sequence.
- SEQ ID NO: 15 is the RNR2 terminator DNA sequence.
- SEQ ID NO: 16 is the SNR52 promoter DNA sequence.
- SEQ ID NO: 17 is the sgRNA DNA sequence.
- SEQ ID NO: 18 is the SUP4 terminator DNA sequence.
- SEQ ID NO: 19 is the Cas9/sgRNA targeting sequence for CLB5 and THI22 intergenic region DNA sequence.
- SEQ ID NO:20 is the Cas9/sgRNA targeting sequence for AAP1 and YHK8 intergenic region DNA sequence.
- SEQ ID NO:21 is the Cas9/sgRNA targeting sequence for AAP1 and YHK8 intergenic region DNA sequence.
- SEQ ID NO:22 is the Cas9/sgRNA targeting sequence for RIB5 gene DNA sequence.
- SEQ ID NO:23 is the MoxRcaBl and MoxRcaEl co-expression cassette DNA sequence.
- SEQ ID NO:24 is the RH01527 DNA sequence.
- SEQ ID NO: 25 is the RH01528 DNA sequence.
- SEQ ID NO:26 is the IDT214 DNA sequence.
- SEQ ID NO:27 is the IDT215 DNA sequence.
- SEQ ID NO:28 is the RH01535 DNA sequence.
- SEQ ID NO:29 is the RH01536 DNA sequence.
- SEQ ID NO:30 is the RH01537 DNA sequence.
- SEQ ID NO:32 is the RH01538 DNA sequence.
- SEQ ID NO:33 is the RH01558 DNA sequence.
- SEQ ID NO:34 is the RH01561 DNA sequence.
- SEQ ID NO:35 is the RH01567 DNA sequence.
- SEQ ID NO:36 is the RH01559 DNA sequence.
- SEQ ID NO:37 is the SmeBluBl cassette DNA sequence.
- SEQ ID NO:38 is the PspBluBl cassette DNA sequence.
- SEQ ID NO:39 is the RH01531 DNA sequence.
- SEQ ID NO:40 is the RH01573 DNA sequence.
- SEQ ID N0:41 is the IDT221 DNA sequence.
- SEQ ID NO:42 is the IDT222 DNA sequence.
- SEQ ID NO:43 is the RH01569 DNA sequence.
- SEQ ID NO:44 is the RHO1570 DNA sequence.
- SEQ ID NO:45 is the RH01571 DNA sequence.
- SEQ ID NO:46 is the RH01572 DNA sequence.
- SEQ ID NO:47 is the RH01216 DNA sequence.
- SEQ ID NO:48 is the RH01219 DNA sequence.
- SEQ ID NO:49 is the S. cerevisiae RIB5 gene sequence.
- SEQ ID NO:50 is the RH01515 DNA sequence.
- SEQ ID N0:51 is the RH01518 DNA sequence.
- SEQ ID NO:52 is the RH01516 DNA sequence.
- SEQ ID NO:53 is the RH01517 DNA sequence.
- SEQ ID NO:54 is the S. eubayanus Rib5 protein sequence.
- SEQ ID NO: 55 is the FBA1 promoter sequence.
- SEQ ID NO:56 is the S. cerevisiae MCH5 gene DNA sequence.
- SEQ ID NO:57 is the S. cerevisiae MCH5 terminator DNA sequence.
- SEQ ID NO:58 is the MCH5 expression cassette DNA sequence.
- SEQ ID NO:59 is the RH01548 DNA sequence.
- SEQ ID NO:60 is the RH01549 DNA sequence.
- SEQ ID NO:61 is the IDT216 DNA sequence.
- SEQ ID NO:62 is the IDT217 DNA sequence.
- SEQ ID NO:63 is the RH01539 DNA sequence.
- SEQ ID NO:64 is the RHO1540 DNA sequence.
- SEQ ID NO:65 is the RH01541 DNA sequence.
- SEQ ID NO:66 is the RH01542 DNA sequence.
- SEQ ID NO:67 is the RH01558 DNA sequence.
- SEQ ID NO:68 is the RH01562 DNA sequence.
- SEQ ID NO:69 is the RH01568 DNA sequence.
- SEQ ID NO:70 is the RH01567 DNA sequence.
- SEQ ID NO:71 is the Cas9/sgRNA targeting sequence of HIS3 gene DNA sequence
- SEQ ID NO:72 is the S. cerevisiae HIS3 gene DNA sequence
- SEQ ID NO:73 is the RH01614 DNA sequence
- SEQ ID NO:74 is the RH01615 DNA sequence
- SEQ ID NO:75 is the RH01616 DNA sequence
- SEQ ID NO:76 is the RH01617 DNA sequence
- SEQ ID NO: 77 is the IDT237 DNA sequence
- SEQ ID NO: 78 is the IDT238 DNA sequence
- SEQ ID NO:79 is the MOXRcaEl full length sequence.
- SEQ ID NO: 80 is the MOXRcaE2 full length sequence.
- SEQ ID NO:81 is the MOXRcaBl full length sequence.
- SEQ ID NO: 82 is the MOCRcaB2 full length sequence.
- SEQ ID NO:83 is the SmeBluBl full length sequence.
- SEQ ID NO: 84 is the PSPBBluBl full length sequence.
- CRISPR Cas9-mediated recombination
- CRISPR can also be used to delete native chromosomal genes and/ or integrate gene constructs during the development of strains (for example, Journal of Microbiological Methods 127:203-205. 2016).
- yeast cell refers to organisms from the phyla Ascomycota and Basidiomycota.
- Exemplary yeast is budding yeast from the order Saccharomycetales.
- Particular examples of yeast are Saccharomyces spp., including but not limited to S. cerevisiae.
- Y east include organisms used for the production of fuel alcohol as well as organisms used for die production of potable alcohol, including specialty and proprietary yeast strains used to make distinctive-tasting beers, wines, and other fermented beverages.
- engineered yeast cells refer to yeast that include genetic modifications and characteristics described herein. Variant/modified yeast do not include naturally occurring yeast.
- proteins Functionally and/or structurally similar proteins are considered to be "related proteins”, or "homologs". Such proteins can be derived from organisms of different genera and/or species, or different classes of organisms (e.g., bacteria and fungi), or artificially designed. Related proteins also encompass homologs determined by primary sequence analysis, determined by secondary' or tertiary' structure analysis, or determined by immunological cross-reactivity, or determined by their functions.
- Disruption of a gene refers broadly to any genetic or chemical manipulation, i.e., mutation, that substantially prevents a cell from producing a function gene product, e.g., a protein, in a host cell.
- Exemplary methods of disruption include complete or partial deletion of any portion of a gene, including a polypeptide-coding sequence, a promoter, an enhancer, or another regulator ⁇ - element, or mutagenesis of the same, where mutagenesis encompasses substitutions, insertions, deletions, inversions, and combinations and variations, thereof, any of which mutations substantially prevent the production of a function gene product.
- a gene can also be disrupted using RNAi, antisense, or any other method that abolishes gene expression.
- a gene can be disrupted by deletion or genetic manipulation of non-adjacent control elements.
- deletion of a gene refers to its removal from the genome ofa host cell.
- a gene includes control elements (e.g., enhancer elements) that are not located immediately adjacent to the coding sequence of a gene
- deletion of a gene refers to the deletion of the coding sequence, and optionally adjacent enhancer elements, including but not limited to, for example, promoter and/or terminator sequences, but does not require the deletion of non-adjacent control elements.
- genetic manipulation and “genetic alteration” are used interchangeably and refer to the alteration/change of a nucleic acid sequence.
- the alteration can include hut is not limited to a substitution, deletion, insertion or chemical modification of at least one nucleic acid in the nucleic acid sequence.
- polypeptide/protein is a protein that possesses an activity, such as an enzymatic activity, a binding activity, a surface-active property, or the like, and which has not been mutagenized, truncated, or otherwise modified to abolish or reduce that activity.
- Functional polypeptides can be thermostable or thermolabile, as specified.
- a functional gene means a gene capable of being used by cellular components to produce an active gene product, typically a protein.
- Functional genes are the antithesis of disrupted genes, which are modified such that they cannot be used by cellular components to produce an active gene product or have areduced ability to be used by cellular components to produce an active gene product.
- yeast cells have been "modified to prevent the production of a specified protein” if they have been genetically or chemically altered to prevent the production of a functional protein/polypeptide that exhibits an activity characteristic of the wild-type protein.
- modifications include, but are not limited to, deletion or disruption of the gene encoding the protein (as described, herein), modification of the gene such that the encoded polypeptide lacks the aforementioned activity, modification of the gene to affect post- translational processing or stability, and combinations, thereof.
- Attenuation of a pathway or “attenuation of the flux through a pathway” i.e., a biochemical pathway, or refers broadly to any genetic or chemical manipulation that reduces or completely stops the flux of biochemical substrates or intermediates through a metabolic pathway. Attenuation of a pathway ' may be achieved by a variety of well-known methods.
- Such methods include but are not limited to: complete or partial deletion of one or more genes, replacing wild-type alleles of these genes with mutant forms encoding enzymes with reduced catalytic activity or increased Km values, modifying the promoters or other regulatory' elements that control the expression of one or more genes, engineering the enzymes or the mRNA encoding these enzymes for a decreased stability, misdirecting enzymes to cellular compartments where they are less likely to interact with substrate and intermediates, the use of interfering RNA, and the like.
- disrupting the biosynthesis of riboflavin refers broadly to any genetic or chemical manipulation that reduces or lessens the overall levels of riboflavin in a cell.
- Disruption of riboflavin biosynthesis may be achieved by a variety' of well-known methods. Such methods include but are not limited to: complete or partial deletion of one or more genes, replacing wild-type alleles of these genes with mutant forms encoding enzymes with reduced catalytic activity or increased Km values, modifying the promoters or other regulatory elements that control the expression of one or more genes, engineering the enzymes or the mRNA encoding these enzymes for a decreased stability, misdirecting enzymes to cellular compartments where they are less likely to interact with substrate and intermediates, the use of interfering RNA, introduction of heterologous genes whose products degrade riboflavin and the like.
- wild-type refers to a naturally-occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more ammo acid positions.
- wild- type refers to a naturally- occurring polynucleotide that does not include a man-made nucleoside change.
- a polynucleotide encoding a wild-type, parental, or reference polypeptide is not limited to a naturally occurring polynucleotide, and encompasses any polynucleotide encoding the wild-type, parental, or reference polypeptide.
- a “mature” polypeptide or variant, thereof, is one in which a signal sequence is absent, for example, cleaved from an immature form of the polypeptide during or following expression of the polypeptide.
- ppt means parts per trillion.
- variant refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an ammo acid.
- variant refers to a polynucleotide that differs in nucleotide sequence from a specified wild-type, parental, or reference polynucleotide. The identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context.
- recombinant when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state.
- recombinant cells express genes that are not found within the native nonrecombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature.
- Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g., a heterologous promoter in an expression vector.
- Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences.
- a vector comprising a nucleic acid encoding a riboflavinase is a recombinant vector.
- isolated refers to a compound, protein (polypeptides), cell, nucleic acid, amino acid, or other specified material or component that is removed from at least one other material or component with which it is naturally associated as found in nature.
- isolated polypeptides includes, but is not limited to, a culture broth containing secreted polypeptide expressed in a heterologous host cell.
- purified refers to material (e.g., an isolated polypeptide or polynucleotide) that is in a relatively pure state, e.g., at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
- enriched refers to material (e.g., an isolated polypeptide or polynucleotide) that is in about 50% pure, at least about 60% pure, at least about 70% pure, or even at least about 70% pure.
- pH range refers to the range of pH values under which the enzyme exhibits catalytic activity.
- pH stable and “pH stability,” with reference to an enzyme, relate to the ability of the enzyme to retain activity over a wide range of pH values for a predetermined period of time (e.g., 15 min., 30 min., 1 hour).
- amino acid sequence is synonymous with the terms “polypeptide,” “protein,” and “peptide,” and are used interchangeably. Where such amino acid sequences exhibit activity, they may be referred to as an “enzyme.”
- the conventional one-letter or three- letter codes for amino acid residues are used, with amino acid sequences being presented in the standard amino-to-carboxy terminal orientation (i.e., N®C).
- nucleic acid encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Nucleic acids may be single stranded or double stranded, and may be chemical modifications. The terms “nucleic acid” and “polynucleotide” are used interchangeably. Because the genetic code is degenerate, more than one codon may be used to encode a particular amino acid, and the present compositions and methods encompass nucleotide sequences that encode a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in 5'-to-3' orientation.
- Hybridization refers to the process by which one strand of nucleic acid forms a duplex with, i.e., base pairs with, a complementary strand, as occurs during blot hybridization techniques and PCR techniques.
- Hybridized, duplex nucleic acids are characterized by a melting temperature (Tm), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleotides within the duplex lower the Tm.
- Very stringent hybridization conditions involve 68°C and 0. IX SSC.
- a “synthetic” molecule is produced by in vitro chemical or enzymatic synthesis rather than by an organism.
- transformed means that the cell contains a non-native (e.g., heterologous) nucleic acid sequence integrated into its genome or carried as an episome that is maintained through multiple generations.
- a “host strain” or “host cell” is an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g., an riboflavinase) has been introduced.
- Exemplary host strains are microorganism cells (e.g., bacteria, filamentous fungi, and yeast) capable of expressing the polypeptide of interest.
- host cell includes protoplasts created from cells
- heterologous with reference to a polynucleotide or protein refers to a polynucleotide or protein that does not naturally occur in a host cell.
- endogenous with reference to a polynucleotide or protein refers to a polynucleotide or protein that occurs naturally in the host cell.
- expression refers to the process by which a polypeptide is produced based on a nucleic acid sequence.
- the process includes both transcription and translation.
- a “selective marker” or “selectable marker” refers to a gene capable of being expressed in a host to facilitate selection of host cells carrying the gene.
- selectable markers include but are not limited to antimicrobials (e.g., hygromycin, bleomycin, or chloramphenicol) and/ or genes that confer a metabolic advantage, such as a nutritional advantage on the host cell.
- a “vector” refers to a polynucleotide sequence designed to introduce nucleic acids into one or more cell types.
- Vectors include cloning vectors, expression vectors, shuttle vectors, plasmids, phage particles, cassettes and the like.
- an “expression vector” refers to a DNA construct comprising a DNA sequence encoding a polypeptide of interest, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host.
- control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation.
- operably linked means that specified components are in a relationship (including but not limited to juxtaposition) permitting them to function in an intended manner.
- a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequences.
- a “signal sequence” is a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell.
- the mature form of an extracellular protein lacks the signal sequence, which is cleaved off during the secretion process.
- a “prosequence” or “secretory tag” is an amino acid sequence between the signal sequence and mature protein that is necessary for the secretion of the protein. Cleavage of the prosequence will result in a mature active protein.
- precursor form of a protein or peptide refers to a mature form of the protein having a prosequence operably linked to the amino or carbonyl terminus of the protein.
- the precursor may also have a “signal” sequence operably linked, to the amino terminus of the prosequence.
- the precursor may also have additional polynucleotides that are involved in post-translational activity (e.g., polynucleotides cleaved therefrom to leave the mature form of a protein or peptide).
- Bioly active refers to a sequence having a specified biological activity, such as an enzymatic activity.
- specific activity refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
- percent sequence identity means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the CLUSTAL W algorithm are:
- Gap extension penalty 0.05
- Deletions are counted as non-identical residues, compared to a reference sequence. Deletions occurring at either terminus are included. For example, a variant with five amino acid deletions of the C-terminus of the mature 617 residue polypeptide would have a percent sequence identity of 99% (612 / 617 identical residues c 100, rounded to the nearest whole number) relative to the mature polypeptide. Such a variant would be encompassed by a variant having “at least 99% sequence identity” to a mature polypeptide.
- “Fused” polypeptide sequences are connected, i.e., operably linked, via a peptide bond between two subject polypeptide sequences.
- filamentous fungi refers to all filamentous forms of the subdivision Eumycotina, particularly Pezizomycotina species.
- malt beverage includes such foam forming fermented malt beverages as full malted beer, ale, dry beer, near beer, light beer, low alcohol beer, low calorie beer, porter, bock beer, stout, malt liquor, non-alcoholic malt liquor and the like.
- malt beverages also includes alternative malt beverages such as fruit flavoured malt beverages, e. g. , citrus flavoured, such as lemon-, orange-, lime-, or berry -flavoured malt beverages, liquor flavoured malt beverages, e. g. , vodka-, rum-, or tequila-flavoured malt liquor, or coffee flavoured malt beverages, such as caffeine-flavoured malt liquor, and the like.
- fruit flavoured malt beverages e. g. , citrus flavoured, such as lemon-, orange-, lime-, or berry -flavoured malt beverages
- liquor flavoured malt beverages e. g. , vodka
- the malt beverage of the instant invention is selected from the group consisting of a beer, ale, dry beer, near beer, light beer, ultra light beer, low alcohol beer, low calorie beer, porter, bock beer, stout, malt liquor, and non-alcoholic malt liquor. More preferably, the malt beverage is a beer.
- beer traditionally refers to an alcoholic beverage denved from malt, which is derived from barley, and optionally adjuncts, such as cereal grains, and flavoured with hops. Beer can be made from a variety of grains by essentially the same process. All grain starches are glucose homopolymers in which the glucose residues are linked by either alpha-1,4- or alpha-1, 6-bonds, with the former predominating.
- the process of making fermented malt beverages is commonly referred to as brewing.
- the principal raw materials used in making these beverages are water, hops and malt.
- adjuncts such as common com grits, refined com grits, rice, sorghum, refined com starch, barley, barley starch, dehusked barley, wheat, wheat starch, torrified cereal, cereal flakes, rye, oats, potato, tapioca, and syrups, such as com syrup, sugar cane syrup, inverted sugar sy p, barley and/or wheat syrups, and the like may be used as a source of starch or fermentable sugar types.
- the starch will eventually be converted into dextrins and fermentable sugars.
- the malt which is produced principally from selected varieties of barley, has the greatest effect on the overall character and quality of the beer.
- the malt is the primary flavouring agent in beer.
- the malt provides the major portion of the fermentable sugar.
- the malt provides the proteins, which will contribute to the body and foam character of the beer.
- the malt provides the necessary enzymatic activity during mashing.
- the “process for making beer” is one that is well known in the art, but briefly, it involves five steps: (a) adjunct cooking and/or mashing (b) wort separation and extraction (c) boiling and hopping of wort (d) cooling, fermentation and storage, and (e) maturation, processing and packaging.
- a) adjunct cooking and/or mashing b
- wort separation and extraction c
- boiling and hopping of wort d
- cooling, fermentation and storage e
- maturation, processing and packaging ed or crushed malt is mixed with water and held for a period of time under controlled temperatures to permit the enzymes present in the malt to, for example, convert the starch present in the malt into fermentable sugars.
- the mash is transferred to a "lauter tun” or mash filter where the liquid is separated from the grain residue. This sweet liquid is called “wort” and the left over grain residue is called “spent grain”.
- the mash is typically subjected to an extraction during mash separation, which involves adding water to the mash in order to recover the residual soluble extract from the spent grain.
- the wort is boiled vigorously. This sterilizes the wort and helps to develop the color, flavor and odor. Hops are added at some point during the boiling.
- the wort is cooled and transferred to a fermenter, which either contains the yeast or to which yeast is added.
- the yeast converts the sugars by fermentation into alcohol and carbon dioxide gas; at the end of fermentation the fermenter is chilled or the fermenter may be chilled to stop fermentation. The yeast flocculates and is removed.
- the beer is cooled and stored for a period of time, during which the beer clarifies and its flavor develops, and any material that might impair the appearance, flavor and shelf life of the beer settles out.
- the beer Prior to packaging, the beer is carbonated and, optionally, filtered and pasteurized. After fermentation, a beverage is obtained which usually contains from about 2% to about 10% alcohol by weight.
- the non-fermentable carbohydrates are not converted during fermentation and form the majority of the dissolved solids in the final beer. This residue remains because of the inability of malt enzymes to hydrolyse the alpha- 1, 6-linkages of the starch and fully degrade the non-starch polysaccharides.
- the non- fermentable carbohydrates contribute less than 50 kilocalories per 12 ounces of a lager beer.
- the “process for making beer” may further be applied in the mashing of any grist.
- fertilization means, in the context of brewing, the transformation of sugars in the wort, by enzymes in the brewing yeast, into ethanol and carbon dioxide with the formation of other fermentation by-products.
- malt is understood as any malted cereal grain, such as barley.
- mash is understood as aqueous starch slurry, e.g. comprising crushed barley malt, crushed barley, and/or other adjunct or a combination hereof, mixed with water later to be separated into wart+spent grains.
- wort refers to the unfermented liquor run-off following extracting the grist during mashing.
- sucrose refers to the drained solids remaining when the grist has been extracted and the wort separated from the mash.
- beer any fermented wort, produced by the brewing and fermentation of a starch-containing material, mainly derived from cereal grains, such as malted barley. Wheat, maize, and rice may also be used.
- non-alcoholic beer or “low-alcohol beer” refers to a beer containing a maximum of 0.1% to 3.5% or 0.1% to 2.5% such as 0.1% to 0.5% alcohol by volume.
- Non-alcoholic beer is brewed by traditional methods, but during the finishing stages of the brewing process the alcohol is removed by vacuum evaporation, by taking advantage of the different boiling points of water and alcohol.
- low-calorie beer or “beer with a low carbohydrate content” is defined as a beer with a carbohydrate content of 1.5 g/100 g or less and with a real degree of fermentation of at least 80%.
- riboflavin-like compounds is defined as compounds containing an isoalloxazine three ring moiety. Examples include riboflavin, riboflavin-5' -phosphate (also known as flavin mononucleotide; FMN), flavin adenine dinucleotide (FAD). Furthermore, these compounds are also known as flavin nucleotides and function as prosthetic groups of oxidation-reduction enzymes.
- riboflavmase is defined as an enzyme capable of hydrolyzing, converting or rearranging riboflavin or riboflavin-like compounds in such a way that the photo- sensitizing action of riboflavin and riboflavin-like compounds is modified, lessened, reduced, eliminated and/or inhibited.
- riboflavin hydrolase is defined as an enzyme that hydrolyzes riboflavin and riboflavin-like compounds, including without limitation lyases (EC 4.3) and nucleosidases (EC 3.2.2). Under some circumstances, the riboflavin hydrolase may produce lumichrone and ribotol as end products.
- riboflavin reductase is defined as an enzyme the reduces riboflavin and riboflavin-like compounds, including without limitation flavin reductases (EC 1.5.1.30).
- riboflavin destructase or ‘ ‘flavin destructase’ ’ is, for example, an enzyme that catalyzes the conversion of flavin mononucleotide (FMN) to 5,6- dimethylbenzimidazole (DMB).
- flavin mononucleotide FMN
- DMB 5,6- dimethylbenzimidazole
- BluB enzymes SmeBluBl (SEQ ID NO:2) and PspBluBl (SEQ ID NO:4)
- the nonphosphorylated counterpart to FNM being riboflavin, also may be converted by a flavin destructase into DMB.
- riboflavinases of the present invention may include any number of conservative amino acid substitutions. Exemplary conservative amino acid substitutions are listed in the following Table.
- the present riboflavinases may be “precursor,” “immature,” or “full-length,” in which case they include a signal sequence, or “mature,” in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the amino acid residue numbering used herein refers to the mature forms of the respective polypeptides.
- the present riboflavinases may also be truncated to remove theN or C- termini, so long as the resulting polypeptides retain riboflavinase activity.
- riboflavinases may be active fragments derived from a longer amino acid sequence. Active fragments are characterized by retaining some or all of the activity of the full length enzyme but have deletions from the N-terminus, from the C-terminus or internally or combinations thereof.
- the present riboflavinases may be a ‘‘chimeric” or “hybrid” polypeptide, in that it includes at least a portion of a first riboflavinase polypeptide, and at least a portion of a second riboflavinase polypeptide.
- the present riboflavinase may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like.
- Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtilis (AmyE or AprE), and Streptomyces CelA
- a flavor stabilized beer having low riboflavin wherein the beer has less than 200 ⁇ g/L of riboflavin.
- 3-methyl-but-2-ene-l-thiol 3-methyl-but-2-ene-l-thiol
- the inventors have discovered the by lowering the amount of riboflavin in beer, formation of 3-MBT is inhibited.
- beer typically has at least 300 ⁇ g/L of riboflavin.
- the beer has less than 100 ⁇ g/L of riboflavin. More preferably, the beer has less than 50 ⁇ g/L of riboflavin. Still more preferably, the beer has less than 10 ⁇ g/L of riboflavin. In still more preferred embodiments, the beer has less than 5 ⁇ g/L of riboflavin. In still other preferred embodiments, the beer has less than 1 ⁇ g/L of riboflavin. Still more preferably, the beer has less than 0.5 ⁇ g/L of riboflavin. Most preferably, the beer has less than 0.1 ⁇ g/L of riboflavin.
- the flavor stabilized beer has less than 50 ppt (parts per trillion) 3MBT. More preferably, the flavor stabilized beer has less 40 ppt 3MBT. Still more preferably, the flavor stabilized beer has less than 30 ppt 4MBT. Yet more preferably, the flavor stabilized beer has less than 20 ppt 3MBT. In yet a more preferred embodiment, the flavor stabilized beer has less than 10 ppt 3MBT.
- the amount of 3MBT in the flavor stabilized beer does not increase more than 20% over 3 months, 6 months or 9 months of storage. More preferably, the amount of 3 MBT does not increase more than 10% over 3 months, 6 months or 9 months of storage. Most preferably, the amount of 3MBT does not increase more than 5% over 3 months, 6 months or 9 months.
- the flavor stabilized beer is a 100% malt- based beer. A 100% malt based beer means a beer made from 100% malt with no adjunct.
- a method for preparing a flavor stabilized beer having low riboflavin comprising fermenting a wort having riboflavin with modified yeast cells, derived from parental yeast cells, the modified yeast cells having disrupted riboflavin biosynthesis, whereby the modified yeast cells deplete the riboflavin in the wort to produce the beer having less than 200 ⁇ g/L of riboflavin.
- the beer has less than 100 ⁇ g/L of riboflavin. More preferably, the beer has less than 50 ⁇ g/L of riboflavin. Still more preferably, the beer has less than 10 ⁇ g/L of riboflavin. In still more preferred embodiments, the beer has less than 5 ⁇ g/L of riboflavin. In still other preferred embodiments, the beer has less than 1 ⁇ g/L of riboflavin. Still more preferably, the beer has less than 0.5 ⁇ g/L of riboflavin. Most preferably, the beer has less than 0.1 ⁇ g/L of riboflavin.
- the modified yeast cells have a genetic disruption of a gene involved in riboflavin biosynthesis.
- the gene is selected from the group consisting of ribl, rib2, rib3, rib4, rib5 or rib7. More preferably, the gene is rib5.
- the modified yeast cells comprise a heterologous nucleic acid encoding Mch5p, providing for enhanced riboflavin uptake by the yeast cell.
- the nucleic acid coding sequence of Mch5p corresponds to SEQ ID NO: 56.
- the Mch5p coding sequence is under the control of a yeast constitutive promoter. Y et more preferably, the promoter is FBA1
- the parental yeast cells are selected from the group consisting of Schizosaccharomyces, Brettanomyces, Kluyveromyces, Yarrowia, Pichia, Candida, Hansenula, Issatchenkia, and Saccharomyces. More preferably, the parental yeast cells are Saccharomyces. Still more preferably, the parental yeast cells are Saccharomyces cerevisiae and Saccharomyces pastorianus.
- the modified yeast cells have a functionally expressed heterologous riboflavinase.
- the riboflavinase is a riboflavin hydrolase.
- the riboflavin hydrolase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaEl (SEQ ID NO:79) or a riboflavin hydrolase active fragment thereof or MOXRcaE2 (SEQ ID NO: 80) or a riboflavin hydrolase active fragment thereof.
- the riboflavinase is a riboflavin reductase. More preferably, the riboflavin reductase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaBl (SEQ ID NO:81) or a riboflavin reductase active fragment thereof or MOXRcaB2 (SEQ ID NO:82) or a riboflavin reductase active fragment thereof.
- the modified yeast cells have a riboflavin reductase and a riboflavin hydrolase.
- the riboflavin reductase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaBl (SEQ ID NO: 81) or a riboflavin reductase active fragment thereof or MOXRcaB2 (SEQ ID NO: 82) or a riboflavin reductase active fragment thereof and the riboflavin hydrolase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to MOXRcaEl (SEQ ID NO:79) or a riboflavin hydrolase active fragment thereof or MOXRcaE2 (SEQ ID NO: 80) or a riboflavin hydrolase active fragment thereof.
- the riboflavinase is a riboflavin destructase. More preferably, the riboflavin destructase is a polypeptide having at least 70%, 80%, 90%, 95%, 99% or 100% sequence identity to SmeBluBl (SEQ ID NO:83) or a riboflavin destructase active fragment thereof or PspBluBl (SEQ ID NO: 84) or a riboflavin destructase active fragment thereof.
- a beer is presented made according to any of the methods discussed above.
- a method for preparing a flavor stabilized beer having reduced riboflavin comprising fermenting a wort having riboflavin with modified yeast cells, derived from parental yeast cells, said modified yeast cells having disrupted riboflavin biosynthesis, whereby the modified yeast cells deplete the riboflavin in the wort to produce beer having at least 10% less riboflavin produced than a beer fermented with the parental yeast cells.
- the beer has at least 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 99% less riboflavin than a beer fermented with the parental yeast cells.
- the parental yeast is Saccharomyces pastorianus.
- the strain is W34/70.
- Yeast strains used here include a larger brewing yeast Saccharomyces pastorianus Weihenstephan 34/70 (Nakao et al. (2009) DNARes. 16: 115-129) and an industrial fuel ethanol production yeast strain FerMaxTM Gold Label Yeast (FG) purchased from Martrex Inc.
- FG FerMaxTM Gold Label Yeast
- SD yeast synthetic
- YNB without Folic Acid and Riboflavin
- 5 g/L ammonium sulfate cells were first grown overnight in SD medium containing 20 mg/L riboflavin, washed in water once, and resuspended in SD medium without riboflavin for 6 hour to overnight to deplete intracellular riboflavin. Cells were then used to inoculate in SD medium containing 0.5 mg/L of riboflavin at a starting OD 600 of 0.5 and grown in aerobic condition at 28°C for 24 hours or m anaerobic condition 28°C for 96 hours.
- SD yeast synthetic
- the analysis used a UHPLC (Ultra high-pressure liquid chromatography) equipped with a quaternary pump, autosampler, column heater, and fluorescence detector.
- the samples were run on aZorbax Eclipse Plus C18 RRHD, particle size 1.8 ⁇ m; DxL: 2.1x50 mm column, column temperature was 40°C, flow rate 0.5 mL/min, injection volume: 10 ⁇ l and fluorescence detection with excitation at 274 nm and emission read at 520 nm for quantification.
- Mobile phase A milli-Q water and mobile phase B: methanol was used with the following gradient min / %B: 0/10; 2/20; 5/21.8; 8/50, 9/50; 10/10 and 12/10.
- the linearity range for Riboflavin was from 1.3 - 2000 ⁇ g/L with a 6-point calibration.
- a reference standard (Riboflavin) was dissolved in DMSO and then serial dilutions were made in Milli-Q water. The stock solution was made fresh each time and protected from light.
- the Riboflavin standard was purchased from Alfa Aesar at 98% purity.
- the DMSO Dimethyl Sulfoxide, ACS
- the stock solution concentration was made using 5 mg of Riboflavin standard into 50 mL of DMSO, which was made in a volumetric flask.
- the serial dilutions were made into approximate concentrations of 2000, 400, 80, 16, 3.2 and 1.3 ⁇ g/L.
- the area count was reported for each standard and plotted on a calibration curve for linearity. The area of the slope was used in reporting the data.
- the samples tested for Riboflavin used the following preparation. Degassed by soni cation or sample rotation. Prepared lOx dilution of sample in Milli-Q water (lOO ⁇ L sample with 900 ⁇ L water).
- Samples were filtrated through 10 kDa molecular weight cutoff spin filter at 15,000 rpm for 30 minutes and then immediately transferred into amber glass HPLC vials with inserts. Samples were run on the UHPLC for analysis. Two sets of calibration standards were run as well as two sets of samples, and the average was taken for data delivery. After the samples were run on the UHPLC, the area count for the riboflavin peak was calculated and reported.
- yeast are modified to produce less riboflavin in the cell and thus consume riboflavin in the media during the brewing fermentation.
- riboflavin reductase FR
- riboflavin hydrolase / monooxygenase FMO
- riboflavin destructase BluB
- the corresponding protein encoded by the MoxRcaBl gene is available as GenBank reference sequence: KTR74700.
- Microbacterium maritypicum RcaEl is designated as the Riboflavin hydrolase. Its homolog (herein named MoxRcaEl) was identified from Microbacterium oxydans strain NS234.
- the nucleotide acid sequence for the full-length MoxRcaEl gene w as identified in the NCBI database (NCBI Reference Sequence: NZ_LDRQ01000062.1 from 12536 to 13915).
- the corresponding protein encoded by the MoxRcaEl gene is identified in the GenBank reference sequence: KTR74697.
- Plasmid pYRH548 includes a co-expression cassette for MoxRcaBl and
- Plasmids pYRH549 and pYRH550 contain S. cerevisiae codon-optimized SmeBluBl (SEQ ID NO:6) or PspBluBl (SEQ ID NO:7) gene under a constitutive modified FBA1 promoter (FBA1L2; SEQ ID NO:3) and FBA1 terminator (SEQ ID NO:8).
- W34/70 Genomic integration of a MoxRcaBl and MoxRcaEl co-expression cassette in W34/70
- the larger brewing yeast Saccharomyces pastorianus Weihenstephan 34/70 (herein named W34/70) is an interspecies hybrid between S. cerevisiae and S. eubayanus and allotetraploid containing approximately one full diploid S. cerevisiae and one full diploid S. eubayanus genome (Nakao et al. (2009) DNARes. 16:115-129). Because of its beter utilization of maltose and maltotriose than other larger yeast, W34/70 strain is used predominantly in modem industrial-scale brewing (Gibson et al. (2013) Yeast 30:255- 266).
- S. cerevisiae genome sequences of W34/70 were used (GenBank accession ABP000000000.1).
- pJT915 was used for Cas9/ gRNA- mediated homology directed recombination.
- the functional and structural composition as well as target sequences for Cas9/ gRNA plasmids, including pJT915, is described in Table 2 and 3.
- MoxRcaBl and MoxRcaEl co-expression cassette (SEQ IDNO:23) was amplified from pYRH548 (Table 1) by standard PCR using primers RH01527 (CACAGCAATAACACAACACAATGGTTAGTAGC; forward; SEQ ID N0 24) and RH01528 (CGTCGATATAGATAATAATGATAATGACAGCAGG; reverse; SEQ ID NO:25). To facilitate more efficient targeted integration, 2 additional DNA fragments were synthesized and amplified to be co-transformed with the expression cassette (illustrated in Figure 1).
- IDT214 (SEQ ID NO:26) is composed of 500bp of 5’- genomic region of the pJT915 target site (SEQ ID NO:19) and 500bp of 5’-end of MoxRcaBl and MoxRcaEl coexpression cassette (SEQ ID NO:23).
- IDT215 (SEQ ID NO:27) is composed of331bp of 3’- end of MoxRcaBl and MoxRcaEl co-expression cassette (SEQ ID NO:23) and 669bp of 3’- genomic region of the pJT915 target site (SEQ ID NO: 19).
- IDT214 was amplified by standard PCR using primers RH01535 (TATTTTGGACATCTATGAAACACC; forward; SEQ ID NO:28) and RH01536 (A ATT AAGT GAGGT GAC AAGGTTT C C ; reverse; SEQ ID NO:29).
- IDT215 was amplified using primers RH01537
- RH01538 TATTTATATTTTGGCTTTACTCTTCATC; reverse; SEQ ID NO:31.
- the amplified fragment was purified / concentrated using DNA Clean & Concentrator-5 (Zymo Research, Irvine, CA), and co-transformed with pJT915. Transformants were selected on YPD agar plates containing 200 mg/L Geneticin (G418).
- PCR primers RH01558 (TAGTCTAAAAAAGAAAGCTCGCACTCAGG; forward; SEQ ID NO:33) and RH01561 (AT GTT GA AAT C GT GGAGAT CAT GT GT GC ; reverse; SEQ ID NO:
- Transformants with correct genomic integration of the expression cassettes were selected for further analysis.
- Cas9/ sgRNA expression plasmid pJT915 was removed from the transformants by growing cells under non-selective media (YPD) and selected single colonies that could not grow on YPD plates containing 200 mg/L Geneticin.
- YPD non-selective media
- Four independent transformants were selected and named RHY1014, RHY1015, RHY1016, and RHY1017.
- SmeBluBl SEQ ID NO:37
- PspBluBl SEQ ID NO:38
- RH01531 GCCTACTTGGCTTCATATACGTTGCATACG; forward; SEQ ID NO:39
- RH01573 ACAATTGGGAAGCATTCAAGGATTGGTACG; reverse; SEQ ID NO:40
- pYRH432 or pYRH433 was used for Cas9/ gRNA- mediated homology directed recombination.
- the functional and structural composition as well as target sequences for pYRH432 and pYRH433 are described in Table 2 and 3.
- IDT221 (SEQ ID NO:41) is composed of 375bp of 5’-genomic region of the pYRH432 and pYRH433 target sites (Table 3) and a common 358bp sequence of 5’-end of SmeBluBl and PspBluBl expression cassettes (SEQ IDNO:37 and 38, respectively).
- IDT222 (SEQ ID NO:42) is composed of a common 375bp sequence of 3’-end of SmeBluBl and PspBluBl expression cassettes (SEQ ID NO:37 and 38, respectively) and 375bp of 3’- genomic region of the pYRH432 and pYRH433 target sites (Table 3).
- IDT221 was amplified by standard PCR using primers RH01569 (TTGGTCCCGAAATTGATCTC; forward; SEQ ID NO:43) and RHO1570 ( TTTTTTGTGGAGACTAAGTCAGAAG ; reverse; SEQ ID NO:44).
- IDT222 (SEQ ID NO:42) was amplified using primers RH01571 (TTAACTTGAATTTATTCTCTAGC; forward; SEQ ID NO:45) and RH01572 (AAT AAATTTTTTGTT GTTCTTT C AGT GC ; reverse; SEQ ID NO:46). The amplified fragment was purified / concentrated using DNA Clean & Concentrator-5 (Zymo Research, Irvine, CA), and co-transformed with pYRH432 or pYRH433.
- Transformants with correct integration of the expression cassette were selected for further analysis.
- Cas9/ sgRNA expression plasmid pYRH432 or pYRH433 was removed from the transformants by growing cells under non-selective media (YPD) and screened single colonies that could not grow on YPD plates containing 200 mg/L Geneticin.
- Independent transformants RHY1012 and RHY1013 contain only the SmeBluBl expression cassette (SEQ ID NO:37).
- Independent transformants RHY1054, RHY1055, and RHY1058 contain the MoxRcaBl and MoxRcaEl co-expression cassette (SEQ ID NO:23) as well as the SmeBluBl expression cassette (SEQ IDNO:37).
- RHY1056, RHY1057, RHY1059, and RHY1060 contain the co-expression cassette (SEQ ID NO:23) for MoxRcaBl and MoxRcaEl, and the PspBluBl expression cassettes (SEQ ID NO:38) ( Figure 2).
- the current example describes riboflavin concentration measurements in wort after brewing W34/70 or its derived strains.
- the brewing procedure was as described in “Materials and Methods”. Briefly, seed cultures were prepared by growing the strains aerobically in 25ml malt extract at 22°C for 3 days in shake flasks. Cells from the seed culture were inoculated in 300ml fresh malt extract to an OD 600 of 1 .0, and fermentation was done at 15°C for 10 days in the dark without shaking. Samples were collected in 1 ml aliquots and immediately stored at ⁇ 80°C until riboflavin assay is performed.
- Figure 3 summarizes the results. Strains expressing SmeBluBl alone or together with RcaBl/RcaEl showed about 5% reduction in riboflavin concentrations in wort after brewing, compared to wild type W34/70 control strain. Strains expressing RcaBl/RcaEl with or without PspBluBl showed about 12% lower riboflavin concentrations compared to the wild type control strain.
- the current example describes protecting beer from generating light-struck flavor by decreasing free flavins in beer.
- Potential solution is to modify yeast to produce less riboflavin in the cell by disrupting riboflavin biosynthetic pathway to make cells consume riboflavin in the media during the brewing fermentation.
- Rib5 is riboflavin synthase which catalyzes the last step of the riboflavin biosynthesis pathway, and deletion of RIB5 gene in S. cerevisiae confers riboflavin auxotrophy (Santos MA, et al. (1995) J Biol Chem 270(1):437- 44).
- Plasmid pYRH553 was constructed to facilitate the double strain break (DSB) within S. cerevisiae RIB5 gene. Functional and structural composition as well as the target sequence of pYRH553 plasmids is described in Table 2 and 3.
- the DSB repair DNA is the annealed product of two complementary single strand DNA molecules, RH01515 (SEQ ID NO:50) and RH01518 (SEQ ID NO:51), which contains 45bp upstream and 45bp downstream sequences of the RIB5 coding sequence, so that complete deletion of S. cerevisiae RIB5 gene occurs when DSB is repaired by homology.
- Fermax Gold (FG) transformants of the DSB repair DNA and pYRH553 were screened by colony PCR using primers RH01516 (SEQ ID NO:52) and RH01517 (SEQ ID NO:53) by standard PCR.
- 0.5kb PCR product was expected when 714bp S. cerevisiae RIB5 gene is deleted. If the RIB5 gene is intact, 1.2kb size band was expected.
- the Cas9/ sgRNA expression plasmid pYRH553 from the rib5 deletion mutants was removed from the transformants by growing cells under non-selective media (YPD) and screened for single colonies that could not grow on YPD plates containing 200 mg/L Geneticin. The rib5 mutant cannot grow without supplement of riboflavin, so 20 mg/L of riboflavin was added to all media.
- Independent transformants RHY1070, RHY1071, and RHY1072 were chosen and stored for further analyses.
- the current example describes the modification of yeast to promote riboflavin transport into the cells by overexpressing riboflavin transporter Mch5.
- the yeast is facilitated to uptake riboflavin in the medium during the brewing fermentation.
- Deletion of RIB5 gene in S. cerevisiae confers riboflavin auxotrophy, and overexpression of Mch5 in rib5 mutant suppress the auxotrophic phenotype (Reihl and Stolz (2005) J. Biol. Chem. 280: 39809 - 39817).
- Plasmid pYRH554 includes an expression cassette for S. cerevisiae MCH5 gene under constitutive FBA1 promoter. The functional and structural composition of plasmid pYRH554 is described in Table 4.
- pJT915 was used for Cas9/ gRNA- mediated homology directed recombination.
- the functional and structural composition as well as target sequences for Cas9/ gRNA plasmids, including pJT915, is described in Table 2 and 3.
- the expression cassette for MCH5 (SEQ ID NO:58) was amplified from pYRH554 using primers RH01548 (TGAACAACAATACCAGCCTTCCAACTTCTG; forward;
- IDT216 SEQ ID NO: 61
- IDT216 is composed of 500bp of 5’-genomic region of the pJT915 target site (SEQ ID NO:19) and 500bp of 5’-end of MCH5 expression cassette (SEQ ID NO:57).
- IDT217 (SEQ ID NO:62) is composed of 184bp of 3’-end of MCH5 expression cassette (SEQ ID NO:57) and 566bp of 3 -genomic region of the pJT915 target site (SEQ ID NO: 19).
- IDT216 (SEQ ID NO:61) was amplified by standard PCR using primers RH01539 (TATTTTGGACATCTATGAAACACC; forward; SEQ ID NO: 63) and RHO 1540 reverse; SEQ ID NO:64).
- IDT217 (SEQ ID NO: 62) was amplified using primers RH01541 (TTTTATTTTTCCGAATTAAAGTCAC; forward; SEQ ID NO:65) and RH01542 (TGAATGGAGGCGAATGCAAGACAG; reverse; SEQ ID NO: 66).
- the amplified fragments were purified and concentrated using DNA Clean & Concentrator-5 (Zymo Research, Irvine, CA), and co-transformed with pJT915.
- Transformants were selected on YPD agar plates containing 200 mg/L Geneticin (G418) and 20 mg/L of riboflavin.
- G418 Geneticin
- RH01558 TAGTCTAAAAAAGAAAGCTCGCACTCAGG; forward; SEQ ID NO:67
- RH01562 AAGTTTTTGTGAGGGCGTAATTGAAGCG; reverse; SEQ ID NO:68
- the current example describes the modification of yeast to promote riboflavin transport into the cells by overexpressing riboflavin transporter Mch5 on a multicopy plasmid.
- RHY1076 and RHY1078 were made to ahistidine auxotroph by deleting HIS3 gene for histidine biosynthesis.
- Plasmid pYRF1573 was constructed to facilitate the double strain break (DSB) in S. cerevisiae HIS3 gene. Functional and structural composition as well as the target sequence of pYRH573 is described in Table 2 and 3.
- the DSB repair DNA is the annealed product of two complementar single strand DNA molecules, RH01614 (SEQ ID NO:73) and RH01615 (SEQ ID NO:74), which contains 45bp upstream and 45bp downstream sequences of the HIS3 coding sequence, so that complete deletion of S. cerevisiae HIS3 gene occurs when DSB is repaired by homology.
- RHY1076 and RHY1078 transformed with the DSB repair DNA and pYRH573 were screened by colony PCR using primers RH01616 (SEQ ID NO:75) and RH01617 (SEQ ID NO:76) by standard PCR.
- a 750 bp PCR product was expected when 660bp S. cerevisiae HIS3 gene is deleted. If the RIB5 gene is intact, 1.4kb size band was expected.
- the Cas9/ sgRNA expression plasmid pYRH573 from the his3 deletion mutants was removed from the mutant by growing cells under non-selective media (YPD) and screening single colonies that could not grow on YPD plates containing 200 mg/L Geneticin.
- YPD non-selective media
- RHY1080 or RHY1081 Two resulting independent his3 mutants were named RHY1080 or RHY1081 and used for the transformation of pYRH554 (Table 4), to express MCH5 gene on a multicopy 2-micron plasmid.
- the pYRH554 transformants were selected on SC-histidine plates and named as RHY1082, RHY1083, RHY1084, and RHY1085.
- Figure 5 summarizes the riboflavin analysis results. The reduction in riboflavin concentrations were similar either in aerobic ( Figure 5 A) or in anaerobic ( Figure 5B) growth condition. The lowest riboflavin concentration was observed with the strain containing rib5 deletion together with multicopy plasmid expression of Mch5, in either growth condition, which showed 14% reduction in riboflavin concentration in the media compared to the parental FG control strain.
- the current example describes a genomic integration of the RcaBl/RcaEl co expression cassette in the strain containing rib5 deletion and multicopy MCH5 expression.
- a strain RHY1083 is used for the transformation.
- MoxRcaBl and MoxRcaEl co-expression cassette (SEQ ID NO:23) is amplified from pYRH548 (Table 1) by standard PCR using primers RH01527 (CACAGCAATAACACAACACAATGGTTAGTAGC; forward; SEQ ID N0 24) and RH01528 (CGTCGATATAGATAATAATGATAATGACAGCAGG; reverse; SEQ ID NO:25).
- RH01527 CACAGCAATAACACAACACAATGGTTAGTAGC; forward; SEQ ID N0 24
- RH01528 CGTCGATATAGATAATAATAATGATAATGACAGCAGG; reverse; SEQ ID NO:25.
- 2 additional DNA fragments are synthesized and amplified to be co-transformed with the expression cassette (illustrated in Figure 1).
- IDT237 (SEQ ID NO:77) is composed of 375bp of 5’-genomic region of the pYRH433 target site (SEQ ID NO:21) and 500bp of 5’-end of MoxRcaBl and MoxRcaEl co-expression cassette (SEQ ID NO:23).
- IDT238 is composed of 33 lbp of 3’-end of MoxRcaBl and MoxRcaEl co-expression cassette (SEQ ID NO:23) and 375bp of 3 - genomic region of the pYRH433 target site (Table 3).
- IDT237 (SEQ ID NO:78) is amplified by standard PCR using primers RH01569 (SEQ ID NO:43) and RH01536 (SEQ ID NO:29). IDT238 is amplified using pnmers RH01537 (SEQ ID NO:30) and RH01572 (SEQ ID NO:
- the amplified fragment is purified / concentrated using DNA Clean & Concentrator- 5 (Zymo Research, Irvine, CA), and co-transformed with pYRH433.
- Transformants are selected on YPD agar plates containing 200 mg/L Geneticin (G418).
- G4108 Geneticin
- primers RH01216 TCTC ATGT AT GAGCGAAT CTTTTT GTGTT AT AGG; forward; SEQ ID NO:47
- RH01561 ATGTTGAAATCGTGGAGATCATGTGTGC; reverse; SEQ ID NO:34
- primers RH01559 are used for 5’- region of the cassette integration confirmation.
- Transformants with correct genomic integration of the expression cassettes are selected for further analysis.
- Cas9/ sgRNA expression plasmid pYRH433 is removed from the transformants by growing cells under non-selective media (YPD) and screening single colonies that cannot grow on YPD plates containing 200 mg/L Geneticin.
- YPD non-selective media
- Four independent transformants are selected for further analyses and named RHY2000-2003.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062976418P | 2020-02-14 | 2020-02-14 | |
PCT/US2021/017800 WO2021163439A1 (en) | 2020-02-14 | 2021-02-12 | Improved yeasts for brewing |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4102997A1 true EP4102997A1 (en) | 2022-12-21 |
Family
ID=74860473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21710731.7A Pending EP4102997A1 (en) | 2020-02-14 | 2021-02-12 | Improved yeasts for brewing |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4102997A1 (en) |
BR (1) | BR112022016099A2 (en) |
WO (1) | WO2021163439A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4238904A1 (en) * | 1992-11-19 | 1994-05-26 | Basf Ag | Riboflavin synthesis in yeast |
US6514542B2 (en) * | 1993-01-12 | 2003-02-04 | Labatt Brewing Company Limited | Treatments for improved beer flavor stability |
WO2017118952A1 (en) * | 2016-01-08 | 2017-07-13 | Sabharanjak Shefali | A method of sequestering riboflavin to prevent formation of skunk beer |
US20200216787A1 (en) * | 2017-09-18 | 2020-07-09 | Dupont Nutrition Biosciences Aps | Riboflavinase enzymes and their use to prevent off flavor in brewing |
-
2021
- 2021-02-12 BR BR112022016099A patent/BR112022016099A2/en unknown
- 2021-02-12 EP EP21710731.7A patent/EP4102997A1/en active Pending
- 2021-02-12 WO PCT/US2021/017800 patent/WO2021163439A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021163439A1 (en) | 2021-08-19 |
BR112022016099A2 (en) | 2022-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20170138543A (en) | Expression constructs and methods for genetically engineering methylnutritic yeast | |
EP3237601B1 (en) | Yeast for preparing alcoholic beverages | |
US20220154113A1 (en) | Expression of heterologous enzymes in yeast for flavoured alcoholic beverage production | |
US20230295601A1 (en) | Aldc production methods | |
CN110804561B (en) | Saccharomyces cerevisiae with high yield of C6-C10 ethyl ester and construction method and application thereof | |
JP3162043B2 (en) | Microorganism producing amylolytic enzymes constructed by recombinant DNA technology and use of the fermentation method | |
CN115997004A (en) | Low diacetyl yeast | |
EP4102997A1 (en) | Improved yeasts for brewing | |
EP3271447B1 (en) | A brewing method | |
US20230407272A1 (en) | Genetically engineered yeast cells and methods of use thereof | |
EP3676362A1 (en) | Riboflavinase enzymes and their use to prevent off flavor in brewing | |
US20240228917A1 (en) | Proteases for beer haze reduction | |
JP2024519089A (en) | Methods and compositions for gamma-decalactone biosynthesis in fermented beverages | |
KR20220052986A (en) | Yeast for beverage preparation without phenolic off-flavor | |
US20210147792A1 (en) | Yeast over-expressing protein phosphatases associated with the hog pathway | |
WO2021150911A1 (en) | Increased ethanol production by overexpression of jid1 in yeast | |
WO2016193420A1 (en) | Use of m4 metalloprotease in wort production | |
JPH05192155A (en) | Gene capable of suppressing production of hydrogen sulfide with yeast and yeast for brewing containing the same gene transduced thereinto | |
JP2012157270A (en) | Yeast exhibiting resistance to glycolaldehyde | |
WO2007026698A1 (en) | Gene causative of the aging smell of malt drink and utilization of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220907 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: INTERNATIONAL N&H DENMARK APS |